GTx, Inc. (NASDAQ:GTXI)

CAPS Rating: 2 out of 5

A biopharmaceutical company dedicated to the discovery, development & commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis & bone loss, muscle wasting & other serious medical conditions.

Recs

0
Player Avatar TraderHater (< 20) Submitted: 11/3/2009 4:55:22 PM : Underperform Start Price: $3.90 GTXI Score: +46.48

These guys are toast

Featured Broker Partners


Advertisement